Pseudophakic ametropia managed with a phakic posterior chamber intraocular lens
Pseudophakic ametropia managed with a phakic posterior chamber intraocular lens
复制标题
使用有晶状体眼后房型人工晶状体治疗假性晶状体眼屈光不正
DOI：
10.1016/s0886-3350(00)00858-0
复制
发表时间：
2001
影响因子：
2.8
通讯作者：
C. de Courten
中科院分区：
文献类型：
--
作者：
A. Chiou;J. Bovet;C. de Courten
我们报告使用有晶状体眼后房型人工透镜（IOL）来矫正人工晶状体眼屈光不正。单侧白内障超声乳化人工晶状体植入术后2例2眼出现屈光不正。第一名患者的明显屈光度为-6.00-0.50 × 50，第二名患者为+4.50-1.00 × 15。两例患者均因屈光参差而困扰，并在人工晶状体眼植入后房型人工晶状体。术后，第1例患者的裸眼视力从20/400改善至20/30，第2例患者的裸眼视力从20/200改善至20/40。显示折射分别为-0.50-0.75 × 55和+1.50-1.50 × 30。未发现并发症。有晶状体眼后房型人工晶状体植入术可能是目前治疗人工晶状体眼屈光不正的一种替代方法。
We report the use of a phakic posterior chamber intraocular lens (IOL) to correct pseudophakic ametropia. Two eyes of 2 patients developed ametropia after unilateral phacoemulsification and IOL implantation. The manifest refraction was −6.00 −0.50 × 50 in the first patient and +4.50 −1.00 × 15 in the second. Both patients were bothered by the induced anisometropia and had posterior chamber phakic IOL implantation in the pseudophakic eye. Postoperatively, uncorrected visual acuity improved from 20/400 to 20/30 in the first patient and from 20/200 to 20/40 in the second patient. The manifest refraction was −0.50 −0.75 × 55 and +1.50 −1.50 × 30, respectively. No complications were noted. Implantation of a phakic posterior chamber IOL may be an alternative to currently available methods of managing pseudophakic ametropia.